ATAD2 and cancer: Moreover, several studies have established that ATAD2 is overexpressed in many cancer types, including lung adenocarcinoma [7], breast cancer [8], colorectal cancer [9], gastric cancer [10], hepatocellular tumor [11], ovarian cancer [12], and cervical cancer [13].